Skip to main content
. 2017 Nov 20;8(64):107612–107620. doi: 10.18632/oncotarget.22544

Figure 2. ROC curves revealed the diagnostic ability of DcR3 for gastric cancer.

Figure 2

Identifications of gastric cancer from healthy controls and other cancers by DcR3 were evaluated using ROC curves. (A) Identification of gastric cancer from healthy controls using the ROC curve; sensitivity = 85.7%, specificity = 90.0%, AUC = 82.3%, threshold = 243.7 pg/mL; (B) Identification of gastric cancer from other cancers using the ROC curve; sensitivity = 85.7%, specificity = 67.4%, AUC = 72.1%, threshold = 257.6 pg/mL.